Want to see AKTS full AI Analyst Report?
Technical Sentiment
Overall Consensus
Strong Sell
1Bullish
6Neutral
13Bearish
Technical Analysis Consensus
Sell
1Bullish
6Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
10Bearish
Aktis Oncology, Inc.’s (AKTS) Moving Averages Convergence Divergence (MACD) indicator is -1.55, suggesting Aktis Oncology, Inc. is a Sell.
Aktis Oncology, Inc.’s (AKTS) 20-Day exponential moving average is 17.53, while Aktis Oncology, Inc.’s (AKTS) share price is $26.92, making it a Sell.
Aktis Oncology, Inc.’s (AKTS) 50-Day exponential moving average is 20.01, while Aktis Oncology, Inc.’s (AKTS) share price is $26.92, making it a Sell.
Aktis Oncology, Inc. (AKTS) Pivot Points
Classic
15.50
15.76
16.26
16.52
17.02
17.28
17.78
Fibonacci
15.76
16.05
16.23
16.52
16.81
16.99
17.28
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Aktis Oncology, Inc. (AKTS) Moving Averages
MA5
16.02Sell
16.12Sell
MA10
16.16Sell
16.44Sell
MA20
17.37Sell
17.53Sell
MA50
21.41Sell
20.01Sell
MA100
22.97Sell
21.20Sell
Aktis Oncology, Inc.’s (AKTS) 10-Day exponential moving average is 16.44, while Aktis Oncology, Inc.’s (AKTS) share price is $26.92, making it a Sell.
Aktis Oncology, Inc.’s (AKTS) 100-Day exponential moving average is 21.20, while Aktis Oncology, Inc.’s (AKTS) share price is $26.92, making it a Sell.
Aktis Oncology, Inc.’s (AKTS) stock price is $26.92 and Aktis Oncology, Inc.’s (AKTS) 50-day simple moving average is 21.41, creating a Sell signal.
Aktis Oncology, Inc.’s (AKTS) stock price is $26.92 and Aktis Oncology, Inc.’s (AKTS) 100-day simple moving average is 22.97, creating a Sell signal.
Aktis Oncology, Inc. (AKTS) Technical Indicators
RSI (14)
31.43
Neutral
STOCH (9,6)
45.53
Neutral
STOCHRSI (14)
37.28
Neutral
MACD (12,26)
-1.55
Sell
ADX (14)
42.78
Neutral
Williams %R
-77.14
Buy
CCI (14)
-80.41
Neutral
ATR (14)
1.03
-
Ultimate Oscillator
41.74
Neutral
ROC
-15.06
Sell
Aktis Oncology, Inc.’s (AKTS) Relative Strength Index (RSI) is 31.43, creating a Neutral signal.
Aktis Oncology, Inc.’s (AKTS) Trend Strength Indicator (ADX) is 42.78, creating a Neutral signal.
Aktis Oncology, Inc.’s (AKTS) Commodity Channel Index (CCI) is -80.41, creating a Neutral signal.
Aktis Oncology, Inc.’s (AKTS) Price Rate of Change (ROC) is -15.06, creating a Sell signal.
FAQ
Is AKTS a Buy, Hold, or Sell?
Based on AKTS’s technical indicators, AKTS is a Strong Sell.
What is AKTS’s RSI (14)?
AKTS’s RSI (14) is 31.43, which suggests AKTS is a Neutral.
What is AKTS’s MACD?
AKTS’s MACD is -1.55, which suggests AKTS is a Sell.
What is AKTS’s 5-day moving average?
AKTS’s 5-day moving average is 16.02, which suggests AKTS is a Sell.
What is AKTS’s 20-day moving average?
AKTS 20-day moving average is 17.37, which suggests AKTS is a Sell.
What is AKTS’s 50-day moving average?
AKTS’s 50-day moving average is 21.41, which suggests AKTS is a Sell.
What is AKTS’s 200-day moving average?
Currently, no data Available
What is AKTS’s Williams % R (14)?
AKTS’s Williams % R (14) is -77.14, which suggests AKTS is a Buy.
What is AKTS’s CCI (14)?
AKTS’s CCI (14) is -80.41, which suggests AKTS is a Neutral.